Privia Health Group, Inc.
PRVA Healthcare Health Information Services
Privia Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 22.3% from fiscal 2024. In the quarter to June 2026, revenue grew 21.4%, EPS grew 250.0% and free cash flow fell 86.2%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
Follow PRVA
Privia Health Group, Inc. (PRVA) EV/Sales
As of 16 October 2026, Privia Health Group, Inc. (PRVA) trades at a EV/Sales of 1.0×. Over the past ten years it has ranged from 0.9× (September 2026) to 5.7× (June 2021); the current reading is higher than 10% of that period. That is below the Health Information Services industry median of 2.6× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.2× | 6.85% |
| FY2024 | 1.1× | (25.73%) |
| FY2023 | 1.5× | (8.31%) |
| FY2022 | 1.6× | (35.49%) |
| FY2021 | 2.5× | (6.88%) |
| FY2020 | 2.6× | 0.00% |
| FY2019 | 2.6× | 0.00% |
| FY2018 | 2.6× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.2× | 26.01% |
| Mar 2026 | 1.0× | (16.43%) |
| Dec 2025 | 1.2× | (11.00%) |
| Sep 2025 | 1.3× | 0.50% |
| 22 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| PRVA Privia Health Group, Inc. | 1.0× |
| OMCL Omnicell, Inc. compare | 1.3× |
| GDRX GoodRx Holdings, Inc. compare | 1.7× |
| OMDA Omada Health, Inc. compare | 2.8× |
| CERT Certara, Inc. compare | 3.7× |
| SDGR Schrodinger, Inc. compare | 4.9× |
| WAY Waystar Holding Corp. compare | 5.4× |
| DOCS Doximity, Inc. compare | 7.6× |
| HTFL Heartflow, Inc. compare | 19.8× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)